Investigating Immunogenicity of IBD Biologics Brochure

A thumbnail preview of our brochure outlining the process of investigating immunogenicity of IBD biologics.

Therapeutic drug monitoring assays can measure the drug, free ADA, and total ADA levels of commonly used IBD Biologics including TNF-alpha blockers, integrin blockers, and interleukin blockers. Drug level and ADA measurements can aid in the investigation of PNR and LOR related to these IBD biologics. Download our brochure to learn more about investigating immunogenicity of IBD biologics.